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Abstract 
Background: Many of lay person believe that opium lowers blood glucose. However some studies show the 
opposite results. In this study, we tried to evaluate the effect of opium on blood glucose and insulin resistance. 
Methods: This comparative study including 53 addicts in case groups who used opium just in the form of 
smoking and 55 non-addicts in a control group, took part in the study, after proving not to be opium users. 
After taking blood samples, their fasting blood glucose (FBG), fasting blood insulin and lipid profiles were 
evaluated. Furthermore, insulin resistance index was analyzed via the homeostatic model assessment of 
insulin resistance (HOMA-IR) formula with the cut-off points of 7.2 and 7.1. 
Findings: Age and gender were not significantly different between the groups. There was no significant 
difference regarding the prevalence of insulin resistance between the two groups, according to the cut-off 
points of 7.1 and 7.2 (P = 0.196 and P = 0.248, respectively). Mean insulin resistance index was not 
significantly different between the two groups (P = 0.325). In the case group, fasting blood insulin was 
considerably lower (P = 0.025) and fasting blood sugar (FBS) was significantly higher (P = 0.016) than the 
control group. 
Conclusion: According to the level of insulin and FBS in addicts, it does not seem that opium has a significant 
effect on reducing the blood glucose and insulin resistance. 
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Introduction 
Around the world, more than 180 million people 
have experienced using illegal drugs at least once 
and 13.5 million have become opium dependent. 
Addiction is one of the important issues of the 21th 
century in the world that is also imperative in 
Iran.1 Inhalation and oral intake are two common 
ways of opium consumption. Opium is 
constituted mostly from morphine, but contains 
more than eight alkaloids with different effects on 
homeostasis.2 After tobacco, opium is an illegal 
drug, which is most used in Iran.1 
One of the common beliefs among diabetic 
patients is that opium can control high blood 
sugar, which explains why some of them turn to 
opium to control their high blood glucose. There 
are not many studies in this regard and our 
information about the effect of opium on 
improving or worsening hyperglycemia is 
limited. The illegality of using opium is one of the 
main reasons why addicts are not willing to 
participate in such studies, and hence there are 
not many samples for this study. Some studies 
have shown a reduction in insulin response after 
taking oral glucose and subsequent glucose 
tolerance.3-5 Some other studies show that opium 
lowers blood glucose6 and in some other studies, 
the glucose tolerance was normal in addicts,7 
whereas some studies showed that opium 
withdrawal worsened hyperglycemia.8 
Because of the controversies in different 
studies, we conducted this study to analyze the 
effect of opium on blood level of glucose. Since 
one of the methods for assessing the effect of any 
substance on blood glucose is considering the 
effect of that substance on insulin resistance, in 
this study the insulin resistance was analyzed 
with the Homeostatic model assessment of insulin 
resistance (HOMA-IR) formula in addicts and was 
then compared with that of the control group. 
Besides insulin resistance, we also analyzed 
insulin serum level and fasting blood sugar (FBS) 
in each group. Based on our knowledge, there is 
no study which evaluates the relationship 
between opium addiction and insulin resistance. 
Methods 
In this comparative study, a group of 53  
opium-addicted individuals and a group of 55 
non addicts were studied. Each individual had a 
specific number. Therefore, in this study no one 
was known by the name. In the first step, all the 
participants filled in the consent form after 
explaining whole of the study. 
The case group subjects were selected from 
people who used opium in the form of smoke. They 
were individuals who had come to Health-care 
centers for check-up. Their addiction was confirmed 
by the morphine test RSA, rapid 
immunochromatography  of urine samples, and the 
positive tests were confirmed again by thin layer 
chromatography (TLC) with high performance TLC 
device (CAMAG model, 2009, Swiss). The opium 
dependency of the case group was confirmed by the 
diagnostic and statistical manual of mental 
disorders-4th Edition (DSM-IV) criteria. 
The control subjects were selected from the other 
people who came to these Health Care Centers and 
they are not addict. All of them had negative results 
for opium addiction after morphine test. Control 
subjects were matched for age and sex and since all 
of the subjects in the control group were cigarette 
smokers as the case subjects. 
Those who had syphilis, hepatitis, human 
immunodeficiency virus (HIV) or other infectious 
diseases, malnutrition, body mass index (BMI) > 
30, diabetes type 2 or even if one of the first 
degree relatives had those problems as well as 
subjects who were taking psychiatric medications 
or corticosteroids were excluded. 
For the first step age, gender and the number 
of years that they use opium (just for case group) 
were noted. Weight and height were measured 
with digital scale tape. Blood samples were 
collected from all participants between 7 and 10 
AM after an overnight fast. Then samples were 
centrifuged and were analyzed for lipid profiles, 
FBS, and fasting blood insulin, then subjects with 
triglyceride (TG) > 250 mg/dl was excluded 
because obesity and insulin resistance may have a 
relationship.9-11 FBS, TG, and cholesterol with 
colorimetry and high-density lipoprotein (HDL) 
with immunoturbidimetric method was measured 
by parsazmon.co kit and auto-analyzer RA1000 
(America/tecknion.co). Insulin was measured 
with radioimmunoassay method by Italian 
radim.co kit. After that, the insulin resistance 
index was calculated by the following formula: 
HOMA-IR = Fast blood insulin × Fast blood 
glucose ÷ 22.5.12,13 
When using the formula, we used the cut-off 
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points of 7.1 and 7.2 and finally, we analyzed the 
data between the two groups using Chi-square 
and Mann–Whitney tests with the statistical 
software SPSS (version 20, SPSS Inc., Chicago,  
IL, USA). 
Results 
There was no significant difference between two 
groups in age, history of addiction and BMI. 
There were 7 women and 46 men in the case 
group and 14 women and 41 men in the control 
group. Gender difference was not significant 
(Table 1). 
Using HOMA-IR ≥ 2.7, just 2 (3.6%) of the 
subjects of the control group had insulin 
resistance, whereas using HOMA-IR ≥ 1.7  
(P = 0.248), 5 subjects (9.1%) in the case group and 
9 subjects (16.4%) in the control group had insulin 
resistance (P = 0.196). After analyzing with chi-
square test, insulin resistant individuals in either 
of these two cut-off points was not significant 
between the addicts and non addicts. 
Mean insulin resistance was not significantly 
different between the groups (case group  
470 ± 80.0, control group 0.97 ± 0.08, P = 0.325). 
Fasting plasma insulin level was significantly 
lower and FBS was significantly higher in the 
addicts than the control group (Table 2). Both TG 
and cholesterol were lower in the case group 
rather than the control group. Cholesterol was 
significantly lower in the case group, however the 
difference of TG was not significant between two 
groups (Table 2). 
Discussion 
In opium-addicted subjects, fasting blood insulin 
levels were significantly lower and FBS levels were 
significantly higher than the control group and 
hence results of our study showed that opium may 
reduce the insulin resistance. 
For the first time in 1936, the phrase of insulin 
resistance was used to describe patients who 
required high dose of insulin. The term resistance 
shows reduced sensitivity to insulin or reduced 
sensitivity to metabolic activity of insulin.14 Insulin 
resistance plays on important role in the 
pathophysiology of diabetes type 2, obesity, 
hyperlipidemia, metabolic syndromes and 
cardiovascular disorders.9-11 Reducing insulin 
resistance, by lifestyle modification and some 
medications, is one of the methods used to treat 
diabetes type 2. 
Recently, a number of studies have been done 
on the effect of opium on blood glucose; however 
there are few studies about the level of blood 
insulin and insulin resistance. Most of these studies 
evaluated diabetics and some of them assessed 
blood factors, including blood glucose and 
hemoglobin A1c (HBA1c) of diabetics without 
considering the effects of opium. 
 
Table 1. Background information of subjects 
Variable Mean Maximum Minimum 
Age (year)    
Case 43.1 55 29 
Control 41.7 51 30 
History of addiction (year)    
Case 8.4 15 4 
BMI (kg/m2)    
Case 26.2 29 22 
Control 25.8 30 23 
BMI: Body mass index 
 
Table 2. Measured indexes in groups 
Index 
Groups 
P Case 
Mean ± SD 
Control 
Mean ± SD 
Fasting serum insulin 3.96 ± 4.69 4.50 ± 2.40 0.025 
Fasting serum glucose 93.03 ± 25.62 83.30 ± 17.70 0.016 
Cholesterol 127.03 ± 39.77 169.47 ± 21.92 < 0.001 
TG 116.21 ± 5.09 142.29 ± 8.66 0.062 
HDL 35.72 ± 1.78 49.14 ± 1.25 < 0.001 
TG: Triglyceride; HDL: High-density lipoprotein; SD: Standard deviation 
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Karam et al.15 did a study on 49 opium addicts 
and 49 non addicts with non-insulin dependent 
diabetes (NIDD). In this study they reported that 
HBA1c levels are significantly higher in opium-
addicted diabetic men rather than non-addicted 
diabetic men but there were no significant 
difference between HBA1c levels in  
opium-addicted diabetic women in comparison to 
non-addicted diabetic women. Rezvanfar et al. 
showed that the HBA1c levels are significantly 
lower in opium-addicted diabetic rather than  
non-addicted diabetics.16 In a study on diabetics 
type 2, Azod et al.6 showed that opium temporarily 
reduced FBS and postprandial glucose, however 
opium did not have any effect on HBA1c and  
long-term blood glucose, these findings were in 
contrast with Karam et al.15 findings. Meanwhile, 
studies such as the study of Sadeghian et al.1 on the 
rats and Asgary et al.17 study in opium addicts 
reject any significant effect of opium on blood 
glucose and HBA1c of non-diabetics. 
Despite different results, the traditional and still 
popular view on the effect of opium on reducing 
blood glucose to treat diabetes continues. In this 
study, we assessed the insulin resistance in opium-
addicts and non-addicts to clarify the effect of 
opium on blood glucose, however our results did 
not show a significant difference between the 
groups. However, lower insulin level in opium 
addicted cases indicated that totally opium cannot 
reduce insulin resistance and improve blood sugar 
by this mechanism. 
It seems that future studies with greater sample 
size and review articles will help to clarify the 
issue. Cigarette smoking can increase insulin 
resistance. One of its mechanisms is making insulin 
resistance by nicotine in skeletal muscles. Because 
of this we select all case and control subject from 
cigarette smokers. 
In our study, we also assessed lipid profiles in 
opium-addicts and the control group. Total 
cholesterol and HDL were significantly lower in 
opium-addicts rather than the non-addicts. TG 
levels were also lower in addicts compared with 
the non-addicts, but not significantly. Reduction of 
TG and cholesterol, by opium, may be beneficial, 
but its effect on lowering HDL can cause many 
complications. Karam et al. showed that there was 
no difference in lipid profiles between NIDD 
mellitus (NIDDM) addicts and non-addict NIDDM 
patients.15 The main limitation of our study was 
that we could not match the amount of opium used 
by any of our subjects. 
Conclusion 
Opium did not decrease insulin resistance, 
however increased FBS and decreased blood 
insulin levels. Therefore, based on the results of 
this study and controversial results of other 
studies, opium is not recommended for 
controlling blood glucose or diabetes. 
On the other hand, because of the differences 
between the results of the studies that have been 
carried out, the effect of opium on reducing TG 
and cholesterol levels cannot justify its use as a 
therapeutic option. Opium can reduce HDL, but 
causes many personal and social complications. 
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